Wales approves new hepatitis C drug while England deliberates

被引：1

|

作者：

Ozieranski, Piotr

King, Lawrence

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2016年 / 355卷

关键词：

D O I：

10.1136/bmj.i6499

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：1

相关论文

共 50 条

[31] Indigenous hepatitis E virus infection in England and Wales
Lewis, H
Morgan, D
Ijaz, S
Boxall, E
BRITISH MEDICAL JOURNAL, 2006, 332 (7556): : 1509 - 1510
[32] US FDA approves a new blood screening test for HIV and hepatitis B and C
不详
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (01) : 5 - 5
[33] The prevalence of hepatitis B infection in adults in England and Wales
Gay, NJ
Hesketh, LM
Osborne, KP
Farrington, CP
Morgan-Capner, P
Miller, E
EPIDEMIOLOGY AND INFECTION, 1999, 122 (01): : 133 - 138
[34] Contaminated blood scandal: solicitors for victims call for hepatitis C screening programme in England and Wales
Mayor, Susan
BMJ-BRITISH MEDICAL JOURNAL, 2019, 365 : l1845
[35] The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a
Harris, KA
Gilham, C
Mortimer, PP
Teo, CG
JOURNAL OF MEDICAL VIROLOGY, 1999, 58 (02) : 127 - 131
[36] US FDA approves boceprevir for treatment of hepatitis C
不详
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (07) : 763 - 763
[37] Hepatitis C: new treatments and drug resistance
Pawlotsky, J-M
ANTIVIRAL THERAPY, 2010, 15 : A5 - A5
[38] FDA Approves Sovaldi for Chronic Hepatitis C (Drug Is Third With Breakthrough Therapy Designation to Receive Such Approval)
不详
CLINICAL INFECTIOUS DISEASES, 2014, 58 (05) : I - I
[39] Mortality in New Zealand and England and Wales
Lessof, Elizabeth
POPULATION STUDIES-A JOURNAL OF DEMOGRAPHY, 1949, 3 (01): : 76 - 99
[40] New radon data for England and Wales
不详
JOURNAL OF RADIOLOGICAL PROTECTION, 2008, 28 (01) : 120 - 121

← 1 2 3 4 5 →